INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $43,605 | -74.8% | 13,500 | -89.6% | 0.00% | -100.0% |
| Q2 2016 | $173,000 | -74.7% | 130,000 | 0.0% | 0.00% | -75.0% |
| Q1 2016 | $685,000 | +22733.3% | 130,000 | +48407.5% | 0.00% | – |
| Q2 2015 | $3,000 | -98.7% | 268 | -98.1% | 0.00% | -100.0% |
| Q4 2014 | $233,000 | -80.4% | 13,804 | -84.0% | 0.00% | -87.5% |
| Q4 2013 | $1,191,000 | -58.5% | 86,295 | -47.5% | 0.01% | -71.4% |
| Q3 2013 | $2,867,000 | -38.1% | 164,521 | -42.5% | 0.03% | -44.0% |
| Q2 2013 | $4,629,000 | – | 285,885 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |